Article Text

Download PDFPDF
Clinical and cost effectiveness of longer prescriptions for chronic conditions

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The evidence on clinical and cost effectiveness of shorter versus longer prescriptions for people with stable chronic conditions treated in primary care has been assessed in a National Institute for Health Research (NIHR) Health Technology Assessment (HTA).1 The study consisted of three elements:

  • a systematic review comparing 28-day prescriptions with longer prescriptions, assessing relevant clinical outcomes, adherence, costs and cost-effectiveness;

  • a cost analysis of relative medication wastage with prescriptions shorter and longer than 60 days; and

  • a decision model …

View Full Text